key: cord-0751347-i7xpg1ty authors: Azmy, Monica C.; Pathak, Shravani; Schiff, Bradley A. title: The Surgical Airway in the COVID-19 Era date: 2022-04-28 journal: Oper Tech Otolayngol Head Neck Surg DOI: 10.1016/j.otot.2022.04.009 sha: b8dae63ff9ae54ea1bbed1636ba9e37b0dda3444 doc_id: 751347 cord_uid: i7xpg1ty OBJECTIVE: We aim to summarize the guidelines for tracheostomy management during the COVID-19 pandemic. METHODS: This is a comparative study analysis and literature review using articles found in the PubMed/MEDLINE database. Here we summarize published work on tracheostomy timing, technique, outcomes, mortality, and decannulation rates during the COVID-19 pandemic, with a focus on expertise from our own institution. RESULTS: Among 12 studies, 2,692 tracheostomies were performed at an average of 17.5 days from intubation. 66.4% were performed open, and 33.6% percutaneously. 85.6% were performed bedside, and 14.4% in the operating room. 19.5% experienced all-cause mortality, and 43.4% were decannulated. In these studies, only 1 proceduralist became infected with COVID-19. DISCUSSION: Early COVID-19 recommendations advocated for tracheostomy a minimum of 14 days from intubation. Currently, tracheostomy is performed more closely to pre-pandemic criteria. Bedside tracheostomy comprised most procedures during the pandemic. Tracheostomy in COVID-19 patients, when performed with techniques to minimize aerosolization, is safe and poses minimal risk of infection to providers performing the procedure. Safe airway management has become a target for innovation, quality improvement, and widespread discussion internationally since the start of the novel Coronavirus disease 2019 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many COVID-19 positive patients become affected with acute respiratory distress syndrome (ARDS), which was an early hallmark of infection. Safe airway management continues to be a topic of evolving recommendations as more information regarding viral variants, infectivity rates, and vaccination become available. Tracheostomy is an important step in the airway algorithm for patients infected with COVID-19 who require prolonged intubation and a need for continued ventilation. This article will focus primarily on the surgical management of the airway in COVID-19 patients. At the start of the pandemic, as many as 10-12% of patients hospitalized with early COVID-19 infection required intubation and mechanical ventilation, and 58% of those required Intensive Care Unit (ICU) level care. 1 As the rates of prolonged mechanical ventilation rose at the start of the pandemic, so did the need for tracheostomy. Management of the surgical airway focused on adaptation to an increased demand with minimization of viral exposure to the healthcare workers and providers involved. A variety of consensus statements, such as from the American Academy of Otolaryngology-Head and Neck Society (AAO-HNS) 2 , the ENT UK and British Laryngological Society 3 , and the New York Head and Neck Society 4 were released, with the objective of standardizing recommendations. Here, we summarize the guidelines for tracheostomy management during the COVID-19 pandemic, with a focus on the methods and management utilized in our institution. This was a literature review and comparative study analysis. We searched the PubMed/MEDLINE database for relevant publications using the search terms tracheostomy, tracheotomy, surgical airway, COVID-19, and SARS-CoV-2 ( Figure 1 ). This was supplemented by reference review. Data from our institution that is referenced in this analysis was previously queried and published by the senior author from two tertiary care hospitals (Moses and Weiler campuses of Montefiore Medical Center) in Bronx, New York. 5,6 12 studies in our literature review included patient data regarding timing, technique, and outcomes of tracheostomy (Table 1) . Across twelve studies, the overall mean time to tracheostomy from time of intubation was 17.5 days (Table 1) The role of tracheostomy in COVID-19 patients has been extensively examined, but obtaining meaningful data is difficult. COVID-19 is a recent disease making large studies and long term follow up difficult. Additionally, it is an ever-changing disease. Differences in variants of the virus, the development of vaccines, the increase in host immunity, and improvements in care complicate summarizing data. In this review, we highlight the literature detailing tracheostomies during the COVID-19 pandemic and discuss current best practices, and how these practices were developed. The benefits of tracheostomy in any critically ill patient include the ability to wean sedation and mechanical ventilation and decrease total intensive care unit (ICU) stay, rates of ventilator-associated pneumonia (VAP), and length of hospital stay. 13, 14 The ability to wean sedation and mechanical ventilation may also reduce ICU delirium, ICU-associated dementia, and post-ICU syndrome. 1 While the timing of tracheostomy continues to be refined, many people recommend tracheostomy for patients who are estimated to need more than 10 days of mechanical ventilation. Before the COVID-19 pandemic, the mean time to tracheostomy among critically ill patients was about 10 days with an overall mortality rate of 14.7%. 15 Early in the pandemic, recommendations advocated against early tracheostomy in order to mitigate the risk of exposure to aerosolizing viral particles, accidental tracheostomy tube dislodgement during proning, and to avoid tracheostomy in those for whom there was a high risk of mortality. 4, 7, 8, 16, 17 Reports suggested as many as 40-68% of patients requiring prolonged ventilation experienced mortality in the beginning of the pandemic. 1, 7 This number has been quoted as high as 88% in some studies. 16 The American Academy of Otolaryngology-Head and Neck Society (AAO-HNS), 2 the ENT UK and British Laryngological Society, 3 York Head and Neck Society, 4 as well as, the majority of the studies reviewed, recommend waiting a minimum of 14 days to tracheostomy, to avoid aerosolizing procedures and the associated risk to providers, in patients who have a high risk of mortality. However, there were some who advocated for early tracheostomy. Angel et al performed 98 percutaneous tracheostomies at a mean time of 10.6 days with a low mortality rate. 18 Kwak et al found that while there was no survival difference between early and late tracheostomy, tracheostomy within 14 days of intubation was associated with shorter duration of ventilation and ICU stay, and late tracheostomy was associated with longer time to ventilator weaning. 12 Farlow et al found each additional day of intubation to be significantly associated with an additional 1.2 days to liberation from the ventilator. 19 After adjusting for demographics, every 1 day increase in time of intubation was also associated with a 3% decreased chance of discharge The factors that support early tracheostomy in pre-covid patients, including decreased duration of translaryngeal intubation, decreasing sedation, improved weaning, and faster mobilization of patients from the ICU, all provide the same benefits to COVID-19 patients as they do to non-COVID patients. Some of the benefits of late tracheostomy in COVID-positive patients, specifically minimizing procedures in patients who will not survive and minimizing risk to health care workers, were more pertinent at the start of the pandemic than they are now. Early compensate for the lack of negative pressure. Since the goal of a negative pressure room is to contain aerosolized particles and protect those outside of the room, and none of these studies address this issue, the recommendation to use a negative pressure room is more theory than data driven. There is a general consensus regarding tracheostomy technique for COVID-positive patients, with the majority of studies reviewed echoing the techniques used at our institution. The procedure is very similar to that in non-COVID patients with some slight modifications to minimize particle aerosolization and risk to providers. Patients should be paralyzed prior to the start of the procedure to eliminate coughing, and anticholinergics may be used as needed to decrease secretions. 4, 6, 8 Since many patients with COVID-19 infection develop poor pulmonary reserve, patients should be preoxygenated with 100% oxygen. As is the case in all tracheostomies, FiO2 levels should then be decreased to less than 50% when cautery is used directly on the trachea. Initially, many suggested that cautery and suction should be minimized, as these can aerosolize particles. 4, 6 However, there is no data to suggest either cautery or suction increases the risk of exposure to healthcare workers, and these can be used judiciously as needed. When the airway is ready to be incised and the tracheostomy tube inserted, the ventilator should be placed on standby to prevent positive pressure aerosolization. The ventilator should be resumed when the tracheostomy tube is in place, the cuff is inflated, and there is a closed system. [4] [5] [6] 8 Although the cessation of ventilation for tube exchange lasts a mere few seconds, providers must be prepared for a patient's inability to tolerate this cessation due to the severity of performing tracheostomy in the pre-pandemic era, apnea immediately before incision into the airway was not a common practice, and so this was not a common issue. The rate of decannulation ranged widely across studies ( Percutaneous and Open Tracheostomy in Patients With COVID-19: The Weill Cornell Experience Tracheotomy Recommendations During the COVID-19 Pandemic Tracheostomy guideline-COVID 19 Tracheostomy during SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck Society Tracheotomy Outcomes in 64 Ventilated COVID-19 Patients at a High Tracheotomy in a High-Volume Center During the COVID-19 Pandemic: Evaluating the Surgeon's Risk. Otolaryngol Head Neck Surg COVID-19 Pandemic: What Every Otolaryngologist-Head and Neck Surgeon Needs to Know for Safe Airway Management Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic The Role of Tracheotomy and Timing of Weaning and Decannulation in Patients Affected by Severe COVID-19 Safety of bedside surgical tracheostomy during COVID-19 pandemic: A retrospective observational study Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain Early Outcomes From Early Tracheostomy for Patients With COVID-19 Early versus late tracheostomy for critically ill patients Tracheotomy timing and outcomes in the critically ill Trends in Tracheostomy for Mechanically Ventilated Patients in the United States Outcomes After Tracheostomy in COVID-19 Patients Long-term intubation and high rate of tracheostomy in COVID-19 patients might determine an unprecedented increase of airway stenoses: a call to action from the European Laryngological Society Novel Percutaneous Tracheostomy for Critically Ill Patients With COVID-19 Tracheostomy for COVID-19 respiratory failure: timing, ventilatory characteristics, and outcomes Systematic review of international guidelines for tracheostomy in COVID-19 patients Tracheostomy During the COVID-19 Pandemic: Comparison of International Perioperative Care Protocols and Practices in 26 Countries Queen Elizabeth Hospital Birmingham COVID-19 airway team. Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods -United States Safety and Prognosis in Percutaneous vs Surgical Tracheostomy in 27 Patients With COVID-19 The safety and efficacy of open bedside tracheotomy: A retrospective analysis of 1000 patients Experience in a University Hospital With Intermediate Follow-up Laryngotracheal Stenosis in Early vs Late Tracheostomy: A Systematic Review